Search for a report

EUROPE STEM CELL MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • EUROPE STEM CELL MARKET FORECAST 2021-2028

EUROPE STEM CELL MARKET FORECAST 2021-2028

The Europe stem cell market is evaluated to grow with a CAGR of 8.03%, over the forecast period of 2021 to 2028. The region’s market growth is fueled by factors like surging medical tourism, significant investments in healthcare facilities and medical research, and the growing incidence of chronic diseases, such as cancer. The Europe stem cell market growth is assessed by analyzing the United Kingdom, Germany, Italy, Poland, France, Russia, Belgium, and the rest of Europe.

EUROPE STEM CELL MARKET FORECAST 2021-2028

Europe Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries and Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) by Product (Adult Stem Cell (Hematopoietic Stem Cell, Neural Stem, Umbilical Cord Stem Cell, Mesenchymal Stem Cell, Dental Stem Cell), Human Embryonic Stem Cell, Pluripotent, Mouse/rat Neural) by Technology (Acquisition (Stem Cell Bone Marrow Market, Stem Cell Apheresis, Stem Cell Umbilical Cord), Cryopreservation, Expansion and Sub-culture, Production (Stem Cell Culture, Therapeutic Cloning, Ivf)) by Application (Regenerative Medicine, Drug Discovery and Development) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy) and by Geography.

Request free sample

The Europe stem cell market is evaluated to grow with a CAGR of 8.03%, over the forecast period of 2021 to 2028. The region’s market growth is fueled by factors like surging medical tourism, significant investments in healthcare facilities and medical research, and the growing incidence of chronic diseases, such as cancer.
europe-stem-cell-market-growth

To learn more about this report, request a free sample copy

The Europe stem cell market growth is assessed by analyzing the United Kingdom, Germany, Italy, Poland, France, Russia, Belgium, and the rest of Europe. According to the Global Cancer Observatory, the United Kingdom recorded more than 446,900 new cancer cases, in 2018. Besides, cancers such as, breast, prostate, skin, and lung are among the most common types of cancers diagnosed in the country. Consequently, stem cell therapies are emerging as a prospective treatment for conditions like Parkinson’s disease, Alzheimer’s disease, cancer, and diabetes, which impact a large population of the United Kingdom. Additionally, the nation is also prominent for its research and development endeavors, across European countries.

On the other hand, according to the 2019 World Population Ageing report, more than 20% of people aged 65 and above, resided in France. This figure is anticipated to increase to more than 24% over the upcoming decade. Hence, as the geriatric population increases, the country market is anticipated to observe substantial growth. Therefore, these factors are expected to drive market growth during the forecast period.

Smith & Nephew PLC, headquartered in the United Kingdom, primarily develops and manufactures trauma endoscopy and orthopedic reconstruction, as well as advanced wound management devices for hospitals and surgeons. The company provides products for computer-assisted surgery, burns, fluid management, grafts or dermal substitutes, donor sites, fracture management, joint fluid therapy, diabetic foot ulcers, etc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      •    KEY DRIVERS
        • SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
        • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
        • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
        • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
        • TECHNOLOGICAL ADVANCEMENTS
      •    KEY RESTRAINTS
        • STRINGENT GOVERNMENT REGULATIONS
        • HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
        • ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
        • LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON STEM CELL MARKET
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • HISTORY OF STEM CELL
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    3. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    4. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY
    3. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • ALLCELLS LLC
        • BECTON, DICKINSON AND COMPANY (BD)
        • CORNING INC
        • CYTORI THERAPEUTICS
        • GE HEALTHCARE
        • INTERNATIONAL STEM CELL CORP
        • MERCK KGAA (SIGMA ALDRICH)
        • MILTENYI BIOTEC
        • PLURISTEM THERAPEUTICS INC
        • QIAGEN NV
        • SMITH & NEPHEW PLC
        • STEMCELL TECHNOLOGIES
        • STRYKER CORPORATION
        • TAKARA HOLDINGS INC
        • THERMO FISHER SCIENTIFIC INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – STEM CELL

    TABLE 2: EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: EUROPE STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: EUROPE STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET

    FIGURES LIST

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020

    FIGURE 6: EUROPE STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE STEM CELL MARKET, BY PRODUCT, IN 2020

    FIGURE 14: EUROPE STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE STEM CELL MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 24: EUROPE STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

    FIGURE 25: EUROPE STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 30: EUROPE STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

    FIGURE 31: EUROPE STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 32: EUROPE STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

    FIGURE 33: EUROPE STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

    FIGURE 34: EUROPE STEM CELL MARKET, BY APPLICATION, IN 2020

    FIGURE 35: EUROPE STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

    FIGURE 36: EUROPE STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

    FIGURE 37: EUROPE STEM CELL MARKET, BY TREATMENT TYPE, IN 2020

    FIGURE 38: EUROPE STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 39: EUROPE STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 40: EUROPE STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 41: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 42: GERMANY STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: FRANCE STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 44: THE UNITED KINGDOM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 45: ITALY STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 46: RUSSIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 47: BELGIUM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: POLAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: REST OF EUROPE STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    2. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    3. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now